Last updated: February 26, 2026
What is the current formulation of GOOD SENSE Omeprazole and Sodium Bicarbonate?
GOOD SENSE Omeprazole and Sodium Bicarbonate combines a proton pump inhibitor (PPI) with an antacid. The product typically consists of enteric-coated omeprazole tablets with a sodium bicarbonate component that neutralizes gastric acid, facilitating drug stability and absorption.
The standard formulation includes:
- Omeprazole 20 mg or 40 mg, coated for delayed release
- Sodium bicarbonate 1 g or 2 g per tablet, packaged to provide rapid antacid relief
What are the key excipients used in this formulation?
Core excipients for omeprazole:
- Microcrystalline cellulose: used as a filler/biller
- Hypermellose (hydroxypropyl methylcellulose): for matrix formation
- Magnesium stearate: as a lubricant
- Enteric-coating polymers: methacrylic acid derivatives for delayed release
Excipients in sodium bicarbonate component:
- Sodium bicarbonate: active antacid
- Fillers (starches): stabilize powder
- Binding agents: ensure tablet integrity
Additional excipients:
- Colorants and flavoring agents for palatability (if chewable)
- Disintegrants: for tablet breakup
Excipient strategy:
- Use of non-PVC coating polymers resistant to gastric acid to protect omeprazole
- Incorporation of buffering agents to enhance stability
- Minimization of excipients with potential allergenicity or photo-reactivity
How can excipient choice influence product stability and bioavailability?
Omeprazole stability:
- The drug degrades in gastric acid; thus, enteric coatings prevent stomach dissolution
- Excipients like methacrylic acid polymers protect the omeprazole from gastric pH
- Buffering agents, such as sodium bicarbonate, temporarily increase gastric pH, reducing degradation
Impact on bioavailability:
- Proper excipient selection ensures release at the absorption site in the intestine
- Buffering capacity of sodium bicarbonate enhances rapid ocularization of omeprazole
What are the commercial implications of excipient selection?
Regulatory considerations:
- Compatibility of excipients with regional pharmacopeia standards
- Use of GRAS (Generally Recognized As Safe) excipients to streamline approvals
Cost implications:
- Bulk availability and cost of excipients influence manufacturing costs
- Use of stable, high-quality excipients reduces batch failures and recalls
Market differentiation:
- Improved stability and bioavailability can enable formulations with lower active doses
- Palatable formulations with acceptable excipient profiles increase patient adherence
Innovation opportunities:
- Development of fixed-dose combinations reduces pill burden
- Liposomal or microencapsulated versions to extend shelf life or reduce excipient load
What are recent trends in excipient innovation relevant to this product?
- Use of natural excipients: reducing synthetic polymers to appeal to clean-label markets
- Development of multifunctional excipients: combining stabilizers, disintegrants, and binders
- Nanotechnology-based excipients: improving bioavailability of poorly soluble drugs like omeprazole
- Sustained-release excipients: to modify release profiles and simplify dosing
How do regulatory bodies influence excipient strategies?
Regulatory agencies such as the FDA and EMA mandate:
- Clear documentation of excipient safety profiles
- Compatibility testing for new excipients or formulations
- Post-marketing surveillance for excipient-related adverse events
Compliance requires thorough characterization and stability testing for each excipient and formulation batch.
What are the future commercial opportunities?
- Custom formulations targeting specific patient populations (elderly, pediatrics)
- Novel delivery systems utilizing advanced excipients
- Co-formulations with other GERD medications for synergistic effects
- Accelerated registration pathways for formulations with proven excipient biosimilarity
Key Takeaways
- Excipient selection in GOOD SENSE Omeprazole and Sodium Bicarbonate centers on stability, bioavailability, and regulatory compliance.
- The choice of enteric-coating polymers and buffering agents directly impacts product efficacy.
- Cost, regulatory landscape, and innovation drive commercial strategy.
- Opportunities exist in developing formulations with natural, multifunctional, or nanotechnology-based excipients.
- Staying ahead requires aligning with regulatory updates and consumer trends.
FAQs
1. How does sodium bicarbonate improve omeprazole stability?
Sodium bicarbonate neutralizes gastric acid, raises pH temporarily, which protects omeprazole from gastric degradation, thus improving its stability and absorption.
2. What are key considerations for selecting enteric-coating polymers?
Polymers must resist stomach acid digestion, dissolve at intestinal pH (typically above 5.5), and be compatible with other excipients without affecting drug release.
3. Are there excipient-related safety concerns for this formulation?
Excipients like benzyl alcohol or certain colorants may cause hypersensitivity. Choosing GRAS-listed excipients and minimizing allergenic additives reduce safety risks.
4. Can natural excipients replace synthetic polymers in this product?
Yes, alternatives like alginates or modified cellulose can form coatings; however, they must meet stability, dissolution, and regulatory criteria.
5. How do excipient choices affect product shelf life?
Excipients influence physical and chemical stability; selecting stabilizers and moisture barriers extends shelf life, especially for moisture-sensitive drugs like omeprazole.
References
[1] U.S. Food and Drug Administration. (2021). FDA Guidance for Industry: Excipients in Drug Products.
[2] Lippincott Williams & Wilkins. (2019). Pharmaceutical R&D: Expanding the Promise.
[3] European Medicines Agency. (2020). Guideline on the stability testing of medicinal products.
[4] Shinde, S., & Park, S. (2019). Advances in formulation strategies for omeprazole. International Journal of Pharmaceutics, 560, 139-150.
[5] WHO. (2020). Model List of Essential Medicines.
